Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001690585-17-000001
Filing Date
2017-05-05
Accepted
2017-05-05 15:27:59
Documents
1
Effectiveness Date
2017-05-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10524
  Complete submission text file 0001690585-17-000001.txt   11583
Mailing Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 4TH FLOOR CAMBRIDGE MA 02142 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-286150 | Film No.: 17818129